The FDA explains that GLP-1 receptor agonists mimic the effects of a natural hormone released by the intestine, help lower blood sugar after eating, and act on brain regions involved in appetite and food intake
Enhances Insulin Sensitivity By reducing insulin resistance, GLP-1 therapy helps your body use glucose more efficiently and store fat in healthier ways
Recent developments: April 2026, The FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, potentially limiting large-scale compounding activities
M., & Wood, J
If side effects are severe or do not improve, talk with your doctor
The GLP-1 Insurance Coverage Checker dramatically simplifies the process for patients by: Saving them time with a quick, easy-to-use online tool